FDC Stock Overview
Manufactures and markets pharmaceutical products in India and internationally.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 5/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for FDC from our risk checks.
FDC Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₹481.35 |
52 Week High | ₹489.95 |
52 Week Low | ₹283.00 |
Beta | 0.22 |
1 Month Change | 8.45% |
3 Month Change | 1.88% |
1 Year Change | 66.01% |
3 Year Change | 46.24% |
5 Year Change | 145.40% |
Change since IPO | 465.30% |
Recent News & Updates
FDC Limited's (NSE:FDC) Price Is Right But Growth Is Lacking
Mar 02Here's Why FDC Limited's (NSE:FDC) CEO May Have Their Pay Bumped Up
Sep 21FDC (NSE:FDC) Seems To Use Debt Quite Sensibly
Sep 15Recent updates
FDC Limited's (NSE:FDC) Price Is Right But Growth Is Lacking
Mar 02Here's Why FDC Limited's (NSE:FDC) CEO May Have Their Pay Bumped Up
Sep 21FDC (NSE:FDC) Seems To Use Debt Quite Sensibly
Sep 15Here's Why FDC Limited's (NSE:FDC) CEO Compensation Is The Least Of Shareholders' Concerns
Sep 16A Look At The Intrinsic Value Of FDC Limited (NSE:FDC)
May 13Weak Statutory Earnings May Not Tell The Whole Story For FDC (NSE:FDC)
Nov 18Here's Why I Think FDC (NSE:FDC) Is An Interesting Stock
Aug 20FDC Limited (NSE:FDC) Just Recorded An Earnings Miss And Analysts Are Updating Their Numbers
May 29Here's Why We Think FDC (NSE:FDC) Is Well Worth Watching
Apr 30What Percentage Of FDC Limited (NSE:FDC) Shares Do Insiders Own?
Mar 11If You Had Bought FDC (NSE:FDC) Shares Five Years Ago You'd Have Earned 63% Returns
Feb 21Declining Stock and Solid Fundamentals: Is The Market Wrong About FDC Limited (NSE:FDC)?
Feb 06With EPS Growth And More, FDC (NSE:FDC) Is Interesting
Jan 19FDC Limited (NSE:FDC) Has Got What It Takes To Be An Attractive Dividend Stock
Dec 29Could The FDC Limited (NSE:FDC) Ownership Structure Tell Us Something Useful?
Dec 08The FDC (NSE:FDC) Share Price Has Gained 79% And Shareholders Are Hoping For More
Nov 12Is FDC Limited's (NSE:FDC) Latest Stock Performance A Reflection Of Its Financial Health?
Oct 22Does FDC (NSE:FDC) Deserve A Spot On Your Watchlist?
Oct 01Estimating The Fair Value Of FDC Limited (NSE:FDC)
Sep 10What Kind Of Shareholders Hold The Majority In FDC Limited's (NSE:FDC) Shares?
Aug 20What You Can Learn From FDC Limited's (NSE:FDC) P/E
Jul 25Is FDC Limited's (NSE:FDC) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?
Jul 07Shareholder Returns
FDC | IN Pharmaceuticals | IN Market | |
---|---|---|---|
7D | 1.8% | 1.9% | 2.9% |
1Y | 66.0% | 62.5% | 45.3% |
Return vs Industry: FDC exceeded the Indian Pharmaceuticals industry which returned 62.5% over the past year.
Return vs Market: FDC exceeded the Indian Market which returned 45.3% over the past year.
Price Volatility
FDC volatility | |
---|---|
FDC Average Weekly Movement | 3.9% |
Pharmaceuticals Industry Average Movement | 5.7% |
Market Average Movement | 6.5% |
10% most volatile stocks in IN Market | 9.5% |
10% least volatile stocks in IN Market | 4.1% |
Stable Share Price: FDC has not had significant price volatility in the past 3 months.
Volatility Over Time: FDC's weekly volatility (4%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1936 | 6,372 | Nandan Chandavarkar | www.fdcindia.com |
FDC Limited manufactures and markets pharmaceutical products in India and internationally. The company offers specialized formulations for various therapeutic segments, including anti-infective, gastrointestinal, ophthalmological, vitamins/minerals/dietary supplements, cardiac, anti-diabetes, respiratory, gynaecology, dermatology, analgesics, and others; and oral rehydration salts. It provides specialized formulations primarily under the Zifi, Ziglim Plus 2, Vitcofol, Pyrimon DF, Zocon, Zoxan, Zathrin, Zipod, Amodep-AT, Zefu, Cotaryl, and Mycoderm brand names.
FDC Limited Fundamentals Summary
FDC fundamental statistics | |
---|---|
Market cap | ₹78.27b |
Earnings (TTM) | ₹2.90b |
Revenue (TTM) | ₹19.16b |
27.0x
P/E Ratio4.1x
P/S RatioIs FDC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
FDC income statement (TTM) | |
---|---|
Revenue | ₹19.16b |
Cost of Revenue | ₹6.90b |
Gross Profit | ₹12.26b |
Other Expenses | ₹9.36b |
Earnings | ₹2.90b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 29, 2024
Earnings per share (EPS) | 17.79 |
Gross Margin | 63.97% |
Net Profit Margin | 15.12% |
Debt/Equity Ratio | 1.2% |
How did FDC perform over the long term?
See historical performance and comparison